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Maternal death is the greatest health disparity globally, with postpartum hemorrhage the 
most common cause. As senior leaders in obstetrics and maternal health from Bolivia, 
Canada, Colombia, Côte d’Ivoire, Honduras, India, Kenya, Nepal, Niger, Norway, Peru, 
Tanzania, the UK, the USA, and Zambia, we are deeply disturbed by recent calls for 
randomized controlled trials (RCTs) of uterine balloon tamponade (UBT) in women with 
uncontrolled postpartum hemorrhage (PPH). Our collective experience, in combination with 
mounting evidence, unequivocally supports the effectiveness of commercial and condom 
UBTs in averting death and disability from PPH associated with atonic uterus. We believe it 
would be highly unethical to embark on an RCT of UBT, now or in the future, unless 
compared with a proven equivalent intervention.  
 
Uterine balloon tamponade was first described 35 years ago as a method to arrest PPH from 
an atonic uterus. Since then, a growing body of evidence supports the efficacy of this 
approach. For example, in a series of women with uncontrolled hemorrhage refractory to all 
other interventions, 160 (98%) of 163 survived after placement of a pre-packaged condom 
uterine balloon [1]. Additionally, among 306 consecutive women with uncontrolled PPH 
across 117 facilities, the survival rate was 99.4% if the UBT device was placed before 
advanced shock (objective signs of neurological and/or cardiovascular compromise) [2]. 
Other evidence includes independently performed near-miss surveys, impact and cost-
effectiveness studies, and the experiences of senior obstetricians’ and midwives’ in averting 
deaths and hysterectomies from their 14 countries and beyond (Table 1). UBT has also 
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influenced surgeons’ behavior by averting emergency hysterectomies [3]. Overall, the 
evidence supports a high degree of efficacy of UBT use among women with PPH in low-
resource settings around the world. 
 
An RCT can only be ethically embarked upon if the condition of equipoise is met. By 
definition, equipoise is present if and only if science and experience have yet to reveal 
whether an intervention in question causes more good or more harm than alternative 
approaches. We stand together in confident solidarity and declare that, based on the current 
evidence generated from both empirical [4] and hypothesis-driven research, there is no 
equipoise in the case of UBT for PPH from an atonic uterus. Therefore, global scale-up of 
UBT and other effective and affordable interventions should be accelerated in an effort to 
end the scourge of unnecessary death and disability from PPH. 
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Table 1 Quotes from 2017 OBGyn meetings  
 
Poonam Shivkumar; Chief of 
ObGyn, Department of 
Obstetrics and Gynecology, 
Mahatma Gandhi Institute for 
Medical Sciences, India  
“My first case of UBT was a sudden massive hemorrhage post C-
section. BP was 40 palpable and then no pulse or BP. UBT 
immediately stopped her bleeding and we brought her back. She 
was discharged 1 week later.” 
“MVA was performed for retained placental tissue with 
associated hemorrhage. Despite MVA and maximum uterotonics, 
pouring of blood worsened. She collapsed and a UBT was 
placed. Bleeding stopped instantly and she was discharged in 
three days.” 
Kshama Kedar; Senior 
ObGyn, Department of 
Obstetrics and Gynaecology, 
Indira Gandhi Government 
Medical College, India 
“Sudden hemorrhage 2 hours post C-section. Raced her to the 
OT and placed a UBT while prepping her. Bleeding arrested and 
no surgery needed” 
“In the year before ESM-UBTTM we did eight hysterectomies for 
PPH. We have done none for 10 months” 
Vidyadhar Bangal; Chief of 
ObGyn, Department of 
Obstetrics & Gynecology, 
Rural Medical College, 
Pravara Institute of Medical 
Sciences (Deemed 
University), India 
“We have saved 14 women from open procedures with UBT this 
year” 
“We did seven or eight hysterectomies for PPH last year, prior to 
UBT. We have only done one this year” 
José Ochoa; Chief of ObGyn, 
Department of Obstetrics and 
Gynecology, Hospital 
General San Felipe, 
Tegucialpa, Honduras 
“Massive hemorrhage soon after delivery, the very evening after 
we were first trained. Quickly moved her to the OT. Placed a UBT 
and wow, we did not need to operate.” 
Apollinaire Horo; Senior 
ObGyn, Department of 
Obstetrics and Gynecology, 
Teaching Hospital of 
Yopougon, Côte d'Ivoire 
“I was very skeptical. I am a gynecology oncologist but cover 
deliveries. But, since UBT training I had two severe emergency 
cases that converted me. They were both too far gone to go to 
the operating room, but we saved them with the UBT” 
Saroja Pande; General 
Secretary of Nepal Society of 
Obstetricians and 
“I have used the condom UBT over 50 times. It absolutely saves 
lives and avoids surgery” 
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Gynaecologists (NESOG), 
Paropakar Maternity and 
Women’s Hospital, Nepal 
Kusum Thapa; President 
Nepal Society of 
Obstetricians and 
Gynaecologists (NESOG) 
and Senior Officer for the 
Jhpiego Maternal & Child 
Survival Program, WA, DC 
USA 
“I brought UBT to Kathmandu over 10 years ago from 
Bangladesh. My colleagues and I have saved many many lives 
with it” 
Vincent Tarimo; Chief of 
ObGyn, Department of 
Obstetrics and Gynecology, 
Muhimbili National Hospital, 
Tanzania 
“The UBT has saved so many women since we started in April of 
2016. We now have a problem training our residents in 
emergency hysterectomy because they are not needed very 
often any longer” 
Monica Oguttu, Executive 
Director of Kisumu Medical 
and Education Trust (KMET) 
and senior nurse midwife, 
Kenya 
“You cannot believe the stories of midwives saving the lives of 
women because of UBT. It is called the magic device” 
 
Abbreviations: ObGyn, obstetrics and gynecology. UBT, uterine balloon tamponade. BP, 
blood pressure. MVA, manual vacuum evacuation. OT, operating theater. ESM-UBT, Every 
Second Matters for Mothers and BabiesTM–UBT. PPH, postpartum hemorrhage.  
 
